Meta‐analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma
- 26 June 2006
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 24 (2) , 281-291
Abstract
Summary: Background: Colorectal cancer may be prevented by reducing the development of adenomatous polyps.Aim: To assess the benefits and harms of antioxidant supplements in preventing colorectal adenoma.Methods: Using the Cochrane Collaboration methodology we reviewed all randomized clinical trials comparing antioxidant supplements with placebo or no intervention. We searched electronic databases and the reference lists until October 2005. Outcome measures were development of colorectal adenoma adverse events. We analysed dichotomous outcomes with fixed‐ and random‐effects model meta‐analyses and calculated the relative risk with 95% confidence interval.Results: We identified eight randomized trials (17 620 participants). Neither fixed‐effect (relative risk: 0.93, 95% CI: 0.81–1.1) nor random‐effect model meta‐analyses (0.82, 0.60–1.1) showed statistically significant effects of supplementation with β‐carotene, vitamins A, C, E and selenium alone or in combination. Antioxidant supplements seemed to increase the development of colorectal adenoma in three low‐bias risk trials (1.2, 0.99–1.4) and significantly decrease its development in five high‐bias risk trials (0.59, 0.47–0.74). The estimates difference is significant (P < 0.0001). There was no significant difference between the intervention groups regarding adverse events, including mortality (0.82, 0.47–1.4).Conclusion: We found no convincing evidence that antioxidant supplements have significant beneficial effect on primary or secondary prevention of colorectal adenoma.Keywords
This publication has 57 references indexed in Scilit:
- Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysisThe Lancet, 2004
- Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and TreatmentClinical Cancer Research, 2004
- Colorectal AdenomasClinical Cancer Research, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Chemoprevention of cancerCarcinogenesis, 2000
- The gastrointestinal tract: A major site of antioxidant action?Free Radical Research, 2000
- Antioxidant Vitamin SupplementsDrug Safety, 1999
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986